Explore

Verastem Oncology Appoints Michael P. Bailey to Board Amid Strategic Growth

Verastem Oncology Appoints Michael P. Bailey to Board Amid Strategic Growth

Verastem Oncology Appoints Michael P. Bailey to Board Amid Strategic Growth

Omios Biologics Launches ODE Platform to Enhance Therapeutic Discovery

Omios Biologics Launches ODE Platform to Enhance Therapeutic Discovery

Omios Biologics Launches ODE Platform to Enhance Therapeutic Discovery

Biomunex Partners with AI Firms to Enhance Cancer Immunotherapy Development

Biomunex Partners with AI Firms to Enhance Cancer Immunotherapy Development

Biomunex Partners with AI Firms to Enhance Cancer Immunotherapy Development

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

Delphia Therapeutics Appoints David P. Kerstein as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein, M.D., as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein, M.D., as Chief Medical Officer to Advance Cancer Therapies

Delphia Therapeutics Appoints David P. Kerstein, M.D., as Chief Medical Officer to Advance Cancer Therapies

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

CordenPharma Acquires AmbioPharm to Enhance U.S. Peptide Manufacturing Capacity

CordenPharma Acquires AmbioPharm to Enhance U.S. Peptide Manufacturing Capacity

CordenPharma Acquires AmbioPharm to Enhance U.S. Peptide Manufacturing Capacity

Crystalys Therapeutics Initiates Phase 2 Trial for Dotinurad in Gout Patients

Crystalys Therapeutics Initiates Phase 2 Trial for Dotinurad in Gout Patients

Crystalys Therapeutics Initiates Phase 2 Trial for Dotinurad in Gout Patients

Olympus Acquires Israeli Medtech Firm BioProtect in $270 Million Deal

Olympus Acquires Israeli Medtech Firm BioProtect in $270 Million Deal

Olympus Acquires Israeli Medtech Firm BioProtect in $270 Million Deal

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference in New York

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference in New York

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference in New York